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Malfunction of synaptic plasticity in different brain regions, including the amygdala plays a
role in impulse control deficits that are characteristics of several psychiatric disorders,
such as ADHD, schizophrenia, depression and addiction. Previously, we discovered
a locus for impulsivity (Impu1) containing the neuregulin 3 (Nrg3) gene, of which
the level of expression determines levels of inhibitory control. MicroRNAs (miRNAs)
are potent regulators of gene expression, and have recently emerged as important
factors contributing to the development of psychiatric disorders. However, their role in
impulsivity, as well as control of Nrg3 expression or malfunction of the amygdala, is
not well established. Here, we used the GeneNetwork database of BXD mice to search
for correlated traits with impulsivity using an overrepresentation analysis to filter for
biologically meaningful traits. We determined that inhibitory control was significantly
correlated with expression of miR-190b, -28a, -340, -219a, and -491 in the amygdala,
and that the overrepresented correlated traits showed a specific pattern of coregulation
with these miRNAs. A bioinformatics analysis identified that miR-190b, by targeting
an Nrg3-related network, could affect synaptic plasticity in the amygdala, targeting bot
impulsive and compulsive traits. Moreover, miR-28a, -340, -219a, and possibly -491 could
act on synaptic function by determining the balance between neuronal outgrowth and
differentiation. We propose that these miRNAs are attractive candidates of regulation
of amygdala synaptic plasticity, possibly during development but also in maintaining the
impulsive phenotype. These results can help us to better understand mechanisms of
synaptic dysregulation in psychiatric disorders.
Keywords: impulsive action, miR-28a, miR-340, miR-219a, miR-491, miR-346, recombinant inbred strain,
bioinformatics
INTRODUCTION
Impulsivity is a personality trait that often occurs in psychiatric
disorders. It is one of the hallmarks of attention deficit hyperac-
tivity disorder (ADHD)(Barkley, 1997), substance abuse, bipolar
disorder and schizophrenia (McElroy et al., 1996; Koob and Le
Moal, 1997; Nestor, 2002; Koob and Volkow, 2010; Lombardo
et al., 2012). Increase in impulsivity has been also reported in
brain injuries (Bechara and Van der Linden, 2005), in Parkinson’s
disease secondary to dopaminergic therapy (Wolters et al., 2008;
Callesen et al., 2013), or Alzheimer’s disease (Rochat et al., 2008).
Impulsivity, or the lack of impulse control, is a multifactorial
construct (Evenden, 1999) that involves both impulsive choice,
and impulsive action; the latter also referred to as the absence
of inhibitory control. High impulsive choice is measured by an
increased preference for an immediate small over a larger but
delayed reward that is more beneficial for the individual. On the
other hand, inhibitory control is the ability to inhibit or hold back
a prepotent response. Thus, a high level of impulsive action is
characterized by poorly conceived, prematurely expressed, unduly
risky, or inappropriate actions that often result in undesirable
consequences in the long-term. Emotional responses typical for
impulsive behavior are orchestrated by several neuronal struc-
tures, among which the amygdala is in part responsible for impul-
sive choice (Gupta et al., 2011) and impulsive action (Depue et al.,
2014), as well as for the compulsive component, like addiction
(Koob, 2009; Koob and Volkow, 2010). The comorbid nature of
impulsivity reflects a multifactorial etiology of psychiatric disor-
ders, and knowledge of its full biological underpinning remains
scarce.
Current models explaining psychiatric illnesses have aban-
doned simple neurotransmitter models, and rather hold dis-
ruptions across whole cellular networks responsible. In this
view, amongst other factors contributing, microRNAs (miR-
NAs), which could modulate expression of network of genes
and proteins, have the potential to bridge the current gap in
our knowledge between the treatment of these debilitating dis-
orders and the underlying neurobiology. After the discovery of
the first miRNA in the early nineties (Lee et al., 1993; Wightman
et al., 1993), these 18–25 nucleotides long, single-stranded, non-
coding RNA species, have emerged as important regulators of
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post-transcriptional gene expression (Ambros and Lee, 2004;
Landgraf et al., 2007; Friedman et al., 2009), including con-
stituents of synaptic structures within neuronal circuits (Siegel
et al., 2011). Typically, a miRNA can target multiple mRNAs,
by binding to its specific miRNA binding site located within
3′-untranslated region (3′-UTR) of each targeted mRNA (Farh
et al., 2005; Lewis et al., 2005). This way a single miRNA can
regulate activity of multiple members of a complex biological
network. Although miRNAs have been linked recently to the
development of psychiatric disorders (Im and Kenny, 2012; Xu
et al., 2012; Nestler, 2014), neurodegenerative diseases (Hébert
and De Strooper, 2009), and actions of drugs of abuse and alcohol
(Pietrzykowski, 2010), a role formiRNAs in impulsivity is not well
established. Thus, far, only some indirect evidence suggests that
miRNAs may play a role in this trait. An association between two
single nucleotide polymorphisms (SNPs) located within the miR-
96 gene and attention deficit/hyperactivity disorder (ADHD) was
reported (Sánchez-Mora et al., 2013). Additionally, an association
between trait impulsivity using self-reporting measures and SNPs
located in a genomic region encoding the 3′-UTR of the SNAP-
25 mRNAs that contain the miR-641 binding site was described
(Németh et al., 2013).
Recently, we used a forward genetic screen in the recombi-
nant inbred mouse set of BXDs (Loos et al., 2014), to question
what factors control levels of inhibitory control. These mice form
a genetic reference population with a fixed genome allowing
assessment of genetic covariance in terms of behavior and mod-
ulation of transcriptional activity (Plomin et al., 1991; Williams
et al., 2001; Peirce et al., 2004; Chesler et al., 2005). We mea-
sured inhibitory control by the 5-choice serial reaction time
task (5CSRTT), a task with face validity to the human continu-
ous performance task, in which attention parameters and motor
impulsivity can be assessed (Cole and Robbins, 1989; Puumala
et al., 1996; Humby et al., 2005). We identified the impulsiv-
ity locus (Impu1) located on chromosome 14 around marker
rs6197032, at 34.5–41.4 Mb (build 37, mm9) (McElroy et al.,
1996; Lombardo et al., 2012; Loos et al., 2014). This locus har-
bors Neuregulin3 (Nrg3), a member of the neuregulin family,
which is important for nervous system development as well as
schizophrenia (Sachs et al., 2000; Barros et al., 2009). The fact
that the C57BL/6J allele contributed to increased impulsivity, that
C57BL/6J mice showed increased Nrg3 expression in the medial
prefrontal cortex (mPFC), a region important for impulsivity, and
that Neuregulins play an important role in central nervous sys-
tem function and neuropsychiatric diseases, culminated in testing
the effect of Nrg3 overexpression in the mPFC on impulsivity.
As hypothesized, higher levels of Nrg3 resulted in higher levels
of impulsive action, whereas loss of Nrg3 decreased impulsive
responding (Palanza, 2001; Krishnan and Nestler, 2011; Loos
et al., 2014; Zhu et al., 2014). Together this showed that regulating
Nrg3 levels is key to impulsivity, in which miRNAs could play an
important role.
With the realization that specific disease symptoms could
occur in several diseases, analysis of intermediate traits, known
as endophenotypes (Almasy and Blangero, 2001; de Geus et al.,
2001; Loos et al., 2009), soon became a popular strategy to find
genetic and molecular underpinning of complex phenotypes.
This strategy has the advantage that animal models, harboring
a fraction of the complexity of the disease, could contribute to
solve the puzzle. Co-occurrence of several of these endopheno-
types in a model could point to a shared molecular mechanism.
In this study we used a bioinformatics approach (Robbins et al.,
2012; Mulligan et al., 2013) to question what behavioral effects
are comorbid with the impulsivity trait (Loos et al., 2014), and
what miRNAs could be driving levels of impulsivity. Therefore,
we performed a comprehensive analysis to first select traits
that are overrepresented with impulsivity, and second to select
microRNAs of which the expression in amygdala is associated
with impulsivity, using GeneNetwork data and several bioinfor-
matic tools. We selected microRNAs based on three criteria; (1)
their location within the Impu1 locus, (2) targeting of the Nrg3
mRNA, and (3) a correlated expression with impulsivity and
comorbid traits. Together, we observed that miRNAs miR-190b,
miR-28a, -219a, -340, and -491-5p may contribute to synaptic
rearrangements and plasticity in the “impulsive” amygdala.
METHODOLOGY
GENENETWORK CORRELATION ANALYSIS
From the GeneNetwork database (http://www.genenetwork.org)
(Rosen et al., 2007), we selected behavioral traits correlated with
motor impulsivity (number of premature pokes; trait #16311) as
measured in the 5CSRTT (Loos et al., 2014) and performed the
analysis in a two-step fashion: (1) we ranked correlations using
Spearman rank test with n-number larger than 15 overlapping
strains, as many traits in the database are from relatively small
cohorts, and with corrected P-value < 0.01; and (2) we per-
formed a trait overrepresentation test using key word searches,
in which significantly correlated traits should be overrepresented
in the GeneNetwork database. Key words representing the trait
of interest were selected to preferably yield ∼50–100 traits upon
searching the GeneNetwork database, in order to get evenly sized
groups based on this search.
For miRNA correlating with impulsivity, we focused
on the amygdala because of its importance in emo-
tional regulation, and because miRNA expression in BXD
mice is well documented in the GeneNetwork database
(http://www.genenetwork.org/dbdoc/INIA_AmgCoh_0311.html)
with expression data available for 50 BXD strains. Significant
correlations were calculated for traits with ≥25 strains in overlap.
Correlation between traits or between traits and amygdala
miRNAs is shown as the correlation coefficient (rho; Pearson
product moment) with two-sided P-value indicated.
microRNA VALIDATION
Expression of miRNAs used for correlation analysis was based
on Affymetrix probes (Table 3) of the GeneNetwork amygdala
database (INIA Amygdala Cohort Affy MoGene 1.0ST (March
11 RMA). We validated each probe set specificity in detecting
miRNA expression by alignment of probe sequences with the
most current mouse genome browser and establishing their loca-
tions to miRNA genes. Location of these genes and sequence
alignment of probe sets to these genes was further validated
by miRBase, a free biological database that acts as an archive
of all miRNA sequences and annotations (Griffiths-Jones, 2006;
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Griffiths-Jones et al., 2006), which also provides naming stan-
dards of microRNAs. Since recently miRNA nomenclature has
changed (Arora et al., 2013), we matched GeneNetwork miRNA
names with the most current miRNA names and used them
throughout the paper (Table 3). Note also that GeneNetwork
and miRBase are using different mouse genome assemblies, each
providing different genomic coordinates for microRNA genes.
Therefore, we used the NCBI Remap tool (http://www.ncbi.nlm.
nih.gov/genome/tools/remap) to convert and match positions
between assembly versions. Also, presence of SNPs in the regions
targeted by probes can affect their efficacy, and may lead to false
gene expression level results. We verified, using GeneNetwork
variant browser, lack of SNPs in the genomic sequences tar-
geted by these probes in both, C57Bl/6J and DBA2/J mice
(Table 3).
TARGETSCAN
We used TargetScanMouse (Release 6.2) to predict mouse miR-
190b-5p targets. Among many miRNA target prediction software
TargetScan seems to be very reliable (Friedman et al., 2009), and
it uses two prediction scores. The aPCT score (a positive score) is
based on the probability of aggregated preferentially conserved
targeting, which is an indicator that a site is conserved due to
selective maintenance of miRNA targeting rather than by chance.
The total context (TC) score (a negative score) provides predic-
tions based on four features of the putative microRNA-binding
site: length of its complementarity to the microRNA’s seed region
(7-mer or 8-mer), position of the complementarity (3′-end),
flanking of the binding site by adenosines, and a position within
the 3′-UTR. To ensure high probability of interactions between
miR-190b-5p and its targets and avoid false-positives we applied
stringent criteria using simultaneously both scores (aPCT > 0.2;
CT < -0.07) thereby selecting the top ∼33% of targets (34 out of
103 total targets) with the highest aPCT score and the lowest TC
score.
GeneMania
We used GeneMania to predict the miR-190b/Nrg3 interac-
tive network. GeneMania is a freely available web interface
designed to determine molecular interactions based on a set
of input genes in different species (Warde-Farley et al., 2010).
We originally input all 34 targets of miR-190b-5p using net-
work weighting as “equal as determined by the network” (see
Figures 4A,C), or using Gene Ontology (GO)-based weighting
for “biological terms” (see Figures 4B,D) to maximize predic-
tion of connectivity between all input genes. GeneMania pro-
vides eight interaction categories (co-expression, co-localization,
physical interaction, genetic interaction, shared protein domains,
pathway co-participation, predicted relationship and other) with
ten to a hundred new genes shown. We restricted our output
data to only ten new genes and three categories (co-expression,
co-localization, physical interaction). We chose these three cate-
gories because they describe the most direct interactions between
molecules. This approach allowed us to obtain a small network of
highly interconnected genes with strong interactions centered on
Nrg3. In a second round, 3 targets, and 4 related genes were used
as input.
In addition, we used GeneMania to perform the func-
tional enrichment analysis based on Gene Ontology (GO) terms
augmented among genes in the network. Only biological terms
with P < 0.05 after correction for the false discovery rate (FDR)
were considered to be enriched. We further used DAVID (The
Database for Annotation, Visualization and Integrated Discovery)
(Huang et al., 2007) and GeneCards (Rebhan et al., 1997) to vali-
date GeneMania results describing association of members of the
Nrg3-network with specific functional terms.
mirPath
DIANA mirPath (Maragkakis et al., 2009) is a freely available
web interface designated by DIANA (DNA Intelligent Analysis)
Laboratory to estimate the impact miRNA effects on biological
pathways. Both the effect of a single miRNA and the combinato-
rial effects of multiple miRNAs are available. After performing an
enrichment analysis mirPath marks positions of miRNA-targeted
genes in biological pathways provided by Kyoto Encyclopedia of
Genes and Genomes (KEGG) (Kanehisa and Goto, 2000). The
KEGG Pathway database is the most comprehensive resource of
interactions of gene products and provides wiring diagrams of
interaction networks. DIANA mirPath output consists of KEGG
pathways sorted according to P value after correction for the
false discovery rate (FDR, Hochberg and Benjamini, 1990). Only
pathways with P < 0.05 were considered to be enriched. Lower
P-value indicates bigger biological impact of miRNA(s) on that
pathway.
RESULTS
CORRELATIONS OF IMPULSIVITY WITH OTHER BEHAVIORAL TRAITS
Impulsivity, measured as the lack of inhibitory control in 5CSRTT
(Loos et al., 2012, 2014), is a characteristic of many psychi-
atric diseases (e.g., ADHD, schizophrenia, depression, addiction),
each represented by complex interactions of several traits. To
understand the role of miRNAs in impulsivity, we first assessed
whether impulsive behavior would correlate with other pheno-
typic traits, as this could be an indication that the genetic make-
up of BXD strains controlling impulsivity play a role in other
traits as well. Using the GeneNetwork database, we performed
the analysis in a two-step fashion: (1) we ranked correlations
using Spearman rank test with n-numbers larger than 15 over-
lapping strains, and with P-values < 0.01; and (2) we performed
a trait overrepresentation test using key word searches, in which
significantly correlated traits should be overrepresented in the
GeneNetwork database. This approach should prevent finding of
a correlation by pure chance, albeit that there still could be a
bias toward studies with more in depth phenotyping. In total,
we selected 34 traits (Table 1, Figure 1). From these 34 traits,
17 compound traits were selected using a Fischer’s exact test
(Table 2, Figure 1). Three of these traits (“Attention/Cognition,”
“Depression/Immobility,” “Metabolism/Body weight gain”) were
overrepresented showing a significant correlation (P < 0.05)
with impulsivity, whereas one trait (“Anxiety/Novel open
field”) showed a trend (P < 0.10) toward overrepresenta-
tion. Although classical parameters of an open field relate to
anxiety, the correlated traits were mostly related to rearing
behavior.
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Table 1 | Correlation of phenotypic traits with impulsivity in BXD mouse strains.
Record Trait description Sample rho P-value Compound trait
16311 Impulsivity measured as motor impulsivity in the 5-choice serial reaction time
task (5CSRT), premature responses before stimulus presentation in males (%)
Attention/
Cognition
13363 Central nervous system, behavior, cognition: response accuracy, measure of
attention in the 5-choice serial reaction time task (5CSRT), Med Associates
5-hole operant chambers, high value = good performance (%)
−0.593 0.000 Attention/Cognition
11432 Central nervous system, behavior: depression assay, immobility using a tail
suspension test (TST) for males (sec below threshold movement level)
−0.800 0.000 Depression/
Immobility
15940 Respiratory exchange ratio m −0.760 0.000 Respiratory
exchange
15623 Trait_44_AUW-BXD Total body weight gain from 8–28 weeks of age (% BW) in
chow-fed males
0.745 0.001 Body weight gain
13370 Central nervous system, behavior, cognition: response accuracy during a session
with variable stimulus duration (1, 0.5, 0.25 s), measure of attention in the
5-choice serial reaction time task (5CSRT), Med Associates 5-hole operant
chambers, high value = good performance (%)
−0.493 0.001 Attention/Cognition
11946 Central nervous system, behavior: Depression assay, immobility using a tail
suspension test (TST) for males and females (sec below threshold movement
level)
−0.690 0.001 Depression/
Immobility
15622 Trait_43_AUW-BXD Total body weight gain from 8–28 weeks of age (grams) in
chow-fed males
0.708 0.001 Body weight gain
15598 Trait_19_AUW-BXD Lean body mass (% BW) at 16 weeks of age in chow-fed
males
−0.683 0.003 Body mass
10665 Infectious disease, immune system: Cytotoxic T-cell (CTL) response (5 × 109 PFU
AdLacZ iv), measured as tumor necrosis factor alpha (TNFa) cytokine expression
(pg/ml)
−0.647 0.003 Immune system
15706 Trait_145_AUW-BXD Water intake (mL) in 24 h in chow-fed males @ 22 weeks of
age
−0.667 0.004 Water intake
15621 Trait_42_AUW-BXD Total body weight gain from 8–16 weeks of age (% BW) in
chow-fed males
0.664 0.004 Body weight gain
15999 Blood Chemistry: AMC Trait 23 0.681 0.004 Blood chemistry
10375 Central nervous system, morphology: Hippocampus weight, bilateral, fixed and
hand-dissected tissue, unadjusted for differences in age, sex, or body weight
(mg)
0.564 0.004 Morphology
hippocampus
12031 Central nervous system, behavior: Novel open field behavior, vertical activity
(rears) from 45–60min in the center for males and females (n beam breaks)
0.451 0.005 Anxiety/Novel open
field
15620 Trait_41_AUW-BXD Total body weight gain from 8–16 weeks of age (grams) in
chow-fed males
0.655 0.005 Body weight gain
13396 Musculoskeletal morphology VDavid102 −0.664 0.006 Muscoskeletal
morphology
11774 Novel open field behavior, vertical activity (rears) from 45–60min in the center for
females (n beam breaks)
0.439 0.006 Anxiety/Novel open
field
11517 Central nervous system, behavior: Novel open field behavior, vertical activity
(rears) from 45–60min in the center for males (n beam breaks)
0.442 0.006 Anxiety/Novel open
field
(Continued)
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Table 1 | Continued
Record Trait description Sample rho P-value Compound trait
12030 Central nervous system, behavior: Novel open field behavior, vertical activity
(rears) from 30–45min in the center for males and females (n beam breaks)
0.436 0.006 Anxiety/Novel open
field
16230 Liver, toxicology, Hepatocyte damage in vitro measured as difference in lactate
dehydrogenase (LDH) release relative to untreated hepatocytes, after 48 h 0.6%
alcohol median in males and females (% LDH increase vs. untreated cells)
0.566 0.006 Liver, toxicology
11283 Central nervous system, visual system: Visual cortex (V1) optical signal strength
to stimulation of ipsilateral eye (intensity)
−0.577 0.007 Visual system
11363 Novel open field behavior, urinations for males (n/test period) −0.432 0.007 Anxiety/Novel open
field
10798 Central nervous system, adult neurogenesis: new astrocyte production level
based on ratio of total BrdU cells to S100b+BrdU labeled cells (residuals of the
ratio)
−0.539 0.007 Neurogenesis
12438 Central nervous system, behavior: Anxiety assay, restraint stress (15min) and
ethanol (1.8 g/kg ip) (RSE group), time in open quadrants using an elevated zero
maze in 60 to 120-day-old males only during 10min (% time)
0.432 0.007 Anxiety stress
maze
10387 Central nervous system, behavior: Seizure threshold pressure at compression
rate of 100 atm hr-1 (100iPc) (also see McCall, 2011, 21384758) (atm)
−0.650 0.007 Seizure
11282 Central nervous system, visual system: visual cortex (V1) optical signal strength
to stimulation of contralateral eye (intensity)
−0.572 0.007 Visual system
12373 Central nervous system, behavior: Anxiety assay, ethanol treated [1.8 g/kg i.p]
(NOE group), activity in closed quadrants using an elevated zero maze in 60 to
120-day-old females only during last 5min (beam breaks/s)
−0.418 0.008 Anxiety stress
maze
10709 Central nervous system, adult neurogenesis: new astrocytes in the dentate
gyrus (n per gyrus)
−0.526 0.009 Neurogenesis
10428 Immune system: lymphocyte major glycoprotein (gp70) xenotropic leukemia
virus envelope-related cell-surface antigen (XenCSA) level (mean fluorescence
value = sum of products of each channel number times the number of spleen
cells in that channel divided by the number of cells counted [units])
0.600 0.009 Immune system
11773 Central nervous system, behavior: novel open field behavior, vertical activity
(rears) from 30–45min in the center for females (n beam breaks)
0.418 0.009 Anxiety/Novel open
field
10439 Pulmonary system, immune system: Airway bronchial constrictor response after
exposure to atracurium, airway pressure time index [cmH2O/s]
0.584 0.010 Immune system
13400 Musculoskeletal morphology VDavid110 −0.615 0.010 Muscoskeletal
morphology
15747 Trait_186_AUW-BXD Food intake (g) in 24 h in high fat-fed males @ 22 weeks of
age (high fat is 60% kcal/fat; chow is 6%, both are 20% protein)
0.632 0.010 Food intake
12016 Central nervous system, behavior: Novel open field behavior, vertical activity
(rears) from 0–60min in the center for males and females (n beam breaks)
0.416 0.010 Anxiety/Novel open
field
The impulsivity trait (16311; bold) was correlated with all available phenotypic traits using GeneNetwork. Traits of the highest significant correlations (P < 0.001)
for n = 15 BXD strains are displayed with their Spearman rank correlation coefficient (Sample rho) sorted by the P-value. Compound traits are color-coded when
overrepresented (see Table 2).
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FIGURE 1 | Correlation of traits with impulsivity in BXD strains. Individual
behavioral traits and their compound traits (colored) are shown. Traits number
IDs are taken from the GeneNetwork records. The impulsivity trait (ID#:16311)
is placed in the center of the figure. Color of lines indicates the direction of the
correlation (blue, negative; red, positive), and line thickness corresponds to the
size of the Spearman rank correlation (thicker line means stronger correlation).
SELECTION AND CORRELATION OF microRNAs WITH IMPULSIVITY
AND COMPOUND TRAITS
The amygdala is involved in emotional regulation of impulsive
behavior, and miRNA expression in this brain region of the
BXD mice is well documented in the GeneNetwork database.
Therefore, we used this miRNA expression dataset to determine
which miRNA correlates with impulsivity and its overrepresented
traits. In addition, two traits (#15598, #15747) were added to
the “Body weight gain” compound trait, as they relate to body
weight and food intake, respectively. In our analysis we used a
comprehensive, three-prong approach of miRNA selection.
First, we selected a miRNA located within a recently estab-
lished impulsivity locus located on chromosome 14 in mice
(Loos et al., 2014) (Figure 2A). Despite a substantial size of
this locus (6.9Mb), it contains only a single miRNA gene
(chr14:34,894,609–34,894,706) called mir-346 (Figure 2B). A
product of the mir-346 gene is a hairpin-shaped mir-346 pre-
cursor, which gives rise to two mature miRNAs: miR-346-5p and
miR-346-3p (Figure 2C), of which the former is a predominant
form. Expression of the miR-346-5p miRNA in BXD mice was
not correlated with impulsivity (Table 3), and therefore was not
included into further analyses.
Second, due to our previous observation of a significant asso-
ciation between Nrg3 gene expression and the lack of inhibitory
control, or impulsive action (Loos et al., 2014), we decided to
determine which miRNAs target murine Nrg3 mRNAs. Based on
the mouse genome browser, the Nrg3 gene produces three dis-
tinct mRNAs, each with a different 3′-UTR length (Figure 2D).
We observed that two of these mRNAs have very short 3′-
UTRs (56 nts) that do not possess any miRNA binding sites.
In contrast, the NM_001190187 mRNA contains a substantially
longer 3′-UTR (1582 nts) with five different miRNA binding
sites grouped into two clusters (Figure 2E). The miRNAs bind-
ing to these sites, i.e., miR-137-3p, miR-155a-5p, miR-190b-5p,
miR-204-5p, miR-30b-5p, miR-30c-5p, miR-30d-5p, miR-30e-
5p, miR-384-3p, were selected for the correlation analysis with
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Table 2 | Selection of overrepresented compound traits correlated with the impulsivity trait (16311).
Compound trait #Correlated traits Total traits in GeneNetwork Representation ratio P-value
Depression/Immobility 2 6 18.14 0.0096
Attention, cognition 2 9 12.09 0.0181
Metabolism/Body weight gain 4 57 3.82 0.0314
Blood chemistry 1 345 0.16 0.0330
Immune system 3 499 0.33 0.0443
Anxiety/Novel open field 7 179 2.13 0.0942
Neurogenesis 2 51 2.13 0.2186
Respiratory exchange 1 18 3.02 0.3045
Food intake 1 18 3.02 0.3045
Muscoskeletal morphology 2 276 0.39 0.3076
Seizure 1 29 1.88 0.4354
Body mass 1 30 1.81 0.4460
Hippocampal morphology 1 48 1.13 0.6050
Anxiety stress maze 2 76 1.43 0.6625
Liver toxicology 1 76 0.72 1.0000
Water intake 1 66 0.82 1.0000
Visual system 2 67 1.62 1.0000
Total 34 1850
From 34 selected traits (see Table 1), 17 compound traits were generated based on key words analysis. The compound traits were sorted on P-value. A two-sided
Fischer’s exact test was used to determine significance of over- or underrepresented traits (P < 0.05, bold), or a presence of a correlation trend (P < 0.10, italics)
using the total number of traits found in the GeneNetwork database. Representation ratio indicates the fold of the over- (black) or under- (gray) represented traits
compared with the original query.
FIGURE 2 | Selection of microRNAs and their relationship with the
impulsivity locus. (A) The impulsivity locus is located on a short arm of
mouse chromosome 14; (B) both, the mir-346 gene and the Nrg3 gene are
located within the locus; (C) the product of the mir-346 gene is a
double-stranded RNA hairpin-like microRNA precursor, which gives rise to
two mature miRNAs: miR-346-5p and miR-346-3p; (D) the Nrg3 gene
produces three mRNAs of different length and composition; (E) only the
longest Nrg3 mRNA (NM_001190187) contains miRNA binding sites.
impulsivity. We established that only miR-190b-5p is signifi-
cantly correlated with impulsive action and that this correlation
is negative, meaning that with increased impulsivity of BXD
mice the expression of miR-190b-5p in the amygdala is lowered.
We further determined correlation of miR-190b-5p with the
overrepresented compound traits and only observed significant
correlations with two metabolic traits (Table 4, Figure 3).
Finally, we established that expression of miR-28a-5p, miR-
219a-5p, miR-340-5p, and miR-491-5p, although not directly
related to the impulsivity locus or Nrg3, is significantly correlated
with the impulsivity trait (Table 3). Three of these miRNAs (miR-
28a-5p, miR-340-5p, and miR-491-5p) were negatively correlated
with impulsivity, whereas expression of miR-219a-5p showed a
positive correlation. Furthermore, the expression of this set of
miRNAs was assessed for correlated expression with the over-
represented compound traits. The expression of miR-340-5p was
strongly and positively correlated with all anxiety traits, most of
which represented rearing behavior (Table 4, Figure 3). Rearing
could probably represent phenotypes of vigilance or learning
(Görisch and Schwarting, 2006). Also, expression of miR-491-
5p was weakly positively correlated with these rearing traits.
Consistent with the positive correlation of miR-28a-5p with
impulsivity, it showed a negative correlation with the attention
traits of the 5CSRTT (Table 4, Figure 3). However, expression of
miR-219a-5p was not correlated with any other trait (Table 4,
Figure 3).
PLAUSIBLE ROLE OF CORRELATED microRNAs IN NEURONAL
FUNCTION
As a next step in identifying putative regulators of impulsiv-
ity and overrepresented compound traits in the amygdala, we
attempted to better understand their role in neuronal function.
Because a single miRNA typically regulates several protein-coding
mRNAs we first established which gene products are, in addi-
tion to Nrg3, miR-190b-5p targets. Subsequently, to determine
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Table 4 | Correlation between overrepresented compound traits and selected microRNAs expressed in amygdala.
Trait # mir-190b mir-28 mir-219-1 mir-340 mir-491 n
rho P rho P rho P rho P rho P
ATTENTION/COGNITION
16311 0.465 0.019 0.513 0.009 −0.488 0.013 0.490 0.013 0.487 0.014 25
13363 0.083 ns −0.510 0.008 0.257 ns −0.002 ns −0.076 ns 26
13370 0.120 ns −0.476 0.014 0.223 ns −0.066 ns −0.096 ns 26
ANXIETY/NOVEL OPEN FIELD
11363 0.240 0.136 −0.158 ns 0.132 ns −0.156 ns −0.297 0.063 40
11517 −0.130 ns 0.182 ns −0.136 ns 0.408 0.010 0.241 0.139 39
11773 −0.181 ns 0.002 ns −0.016 ns 0.507 0.001 0.288 0.072 40
11774 −0.154 ns 0.026 ns 0.029 ns 0.439 0.005 0.300 0.060 40
12016 −0.171 ns 0.031 ns −0.031 ns 0.480 0.002 0.271 0.090 40
12030 −0.177 ns 0.080 ns −0.059 ns 0.476 0.002 0.280 0.080 40
12031 −0.148 ns 0.114 ns −0.048 ns 0.434 0.005 0.277 0.084 40
METABOLISM/BODY WEIGHT GAIN
15620 −0.353 0.041 0.160 ns −0.078 ns 0.209 ns 0.147 ns 34
15621 −0.336 0.052 0.294 0.091 −0.174 ns 0.182 ns 0.015 ns 34
15622 −0.155 ns −0.011 ns −0.272 ns 0.077 ns 0.127 ns 34
15623 −0.184 ns 0.059 ns −0.089 ns 0.028 ns 0.154 ns 34
15598 0.375 0.029 −0.106 ns −0.061 ns −0.269 0.124 −0.317 0.068 34
15747 −0.351 0.042 0.394 0.021 0.354 0.040 0.350 0.042 0.274 0.117 34
For three significantly impulsivity-correlated compound traits, the individual traits are shown. In addition, two traits (#15598, #15747) were added to the Body weight
gain compound trait, as they relate to body weight and food intake, respectively. Trait numbers correspond to traits are described in Table 1, and trait color indicates
the correlation with impulsivity (red, positive; blue negative) Sample rho and P-value of Pearson correlation (n ≥ 25 strains), as well as well as n-number in overlap,
with miRNA correlation are shown. P-values < 0.2 are indicated, otherwise non-significant (ns; gray); P-values < 0.05 indicates significant correlation (bold). Traits
with n < 25 strains in overlap with miRNA expression are not shown.
the Nrg3-related network of miR-190b-5p targets, we predicted
biological interactions of these gene products with Nrg3, as well as
their functional importance using TargetScanMouse, GeneMania
and DAVID (Huang et al., 2007; Friedman et al., 2009; Warde-
Farley et al., 2010), respectively.
We applied stringent TargetScan conditions and selected only
targets with simultaneously a high aPCT score and a low total
context score (top 33% of all targets; see Methodology). This
approach, ensuring selection of high probability interactions
between miR-190b-5p and its targets, yielded 34 genes (Table 5).
In order to view genes that are related to the Nrg3 network, the 34
selected targets underwent an interaction network analysis using
GeneMania, in which we only selected gene products directly
linked to Nrg3, based on evidence indicating co-localization,
co-expression and physical interaction with Nrg3, for different
network weighting (Figures 4A,B). Besides three miR-190b-5p
targets (Myo5a, Celf6, and Nlgn1) interacting directly with Nrg3,
we also discovered additional gene products as members of the
Nrg3 network, which were ErbB4, the receptor of Nrg3, and Grlb,
the b-subunit of the glycine receptor (Figure 4A). In addition,
the adhesion molecule Nrxn1, and the complement compo-
nent C1ql3 (Figure 4B) were detected. In order to evaluate an
Nrg3-network of closely interacting gene products, we took these
eight genes for a second round of establishing gene interactions
(Figures 4C,D). Relationships of each gene with a particular bio-
logical term within each process are shown in Table 6. It appears
that this network contributes mostly to three biological pro-
cesses, all of them pertinent to the neuronal (synaptic) function
(Figures 4C,D). Thus, miR-190b-5p, via its targets and genes
within the Nrg3-network, seems to control synaptic activity.
For the other miRNAs, miR-28a-5p, miR-219a-5p, miR-340-
5p, and miR-491-5p, which were significantly correlated with
the impulsivity trait (Table 3), the expression of three (miR-28a-
5p, miR-340-5p, and miR-491-5p) was correlated in the same
direction (positive correlation) with the impulsivity trait, whereas
the expression of miR-219a-5p was correlated in the opposite
direction. Typically, miRNAs work as gene product suppressors;
increased expression of a miRNA decreases expression of its tar-
gets, while decreased expression of a miRNA increases expression
of its targets. To understand the contribution of these miRNAs
to biological processes, we uploaded all three positively corre-
lated microRNAs as a one group and the negatively correlated
microRNA (miR-219a-5p) as a second group into mirPath v2.0
(Vlachos et al., 2012). This program allows for determination of
interactions of pathways regulated by multiple miRNAs or a sin-
gle miRNA. The simultaneous input of all 4 miRNAs, although
possible, would make it difficult to distinguish down-regulated
from up-regulated effects of miRNAs on their targets. The top
five of enriched, neuronal function-related pathways are shown
in Table 7 (upper part) with the axonal guidance pathway being
regulated most. We next determined in a similar fashion path-
ways regulated by miR-219a-5p, a brain-specific miRNA. Axonal
www.frontiersin.org December 2014 | Volume 8 | Article 389 | 9
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FIGURE 3 | Impulsivity-related microRNA expression network in
amygdala. Amygdala miRNAs (green circles) of which the expression is
correlated with impulsivity (lack of inhibitory control) (Table 3) are shown.
Correlation of miRNAs with impulsivity and compound traits are shown
as lines. Colors of lines indicate the direction of the correlation (blue,
negative; red, positive), intensity of the color depicts P-value of Pearson
correlation (one sided: dark, P < 0.05; light, P < 0.10) and line thickness
corresponds to the size of the Pearson rank correlation (thicker line
means stronger correlation). This network is overlaid on the impulsivity
correlation trait network from Figure 1 (faded colors) to show
relationship of traits and miRNAs. For the GeneNetwork IDs of individual
traits see Table 1.
guidance also appeared to be one of the pathways targeted by
miR-219a-5p (Table 7, lower part). Since miR-219a-5p is cor-
related with impulsivity in an opposite direction as the three
other miRNAs, it could attenuate some of the effect of these
miRNAs. Figure 5 shows the axonal guidance pathway with gene
products targeted by specific miRNAs used in this study. Axonal
guidance is controlled by several guidance cues (netrins, ephrins,
slits and semaphorins), which affect axonal attraction, repulsion
Frontiers in Neuroscience | Neurogenomics December 2014 | Volume 8 | Article 389 | 10
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Table 5 | Targets of miR-190b.
# Gene symbol mRNA accession # Gene full name aPCT score TC score
1 Dennd5b NM_177192 DENN/MADD domain containing 5B 0.44 −0.42
2 Dmd NM_007868 Dystrophin, muscular dystrophy 0.44 −0.33
3 Tnrc6b NM_144812 Trinucleotide repeat containing 6b 0.44 −0.31
4 Kcnq5 NM_001160139 Potassium voltage-gated channel, subfamily Q, member 5 0.44 −0.30
5 Irs4 NM_010572 Insulin receptor substrate 4 0.43 −0.28
6 Trp53inp1 NM_001199105 Transformation related protein 53 inducible nuclear protein 1 0.42 −0.27
7 Epc2 NM_172663 Enhancer of polycomb homolog 2 (Drosophila) 0.40 −0.37
8 Gphn NM_145965 Gephyrin 0.40 −0.27
9 Celf4 NM_001146292 CUGBP, Elav-like family member 4 0.40 −0.21
10 Fgf14 NM_010201 Fibroblast growth factor 14 0.40 −0.16
11 Setbp1 NM_053099 SET binding protein 1 0.37 −0.26
12 Tnrc6a NM_144925 Trinucleotide repeat containing 6a 0.35 −0.31
13 Myo5a NM_010864 myosin 5A 0.30 −0.36
14 Samd4 NM_001037221 Sterile alpha motif domain containing 4 0.30 −0.28
15 Foxp2 NM_053242 Forkhead box P2 0.30 −0.21
16 Tnrc6c NM_198022 Trinucleotide repeat containing 6C 0.27 −0.22
17 Bai3 NM_175642 Brain-specific angiogenesis inhibitor 3 0.24 −0.34
18 Stc1 NM_009285 Stanniocalcin 1 0.23 −0.45
19 Nlgn1 NM_001163387 Neuroligin 1 0.23 −0.40
20 Arpc5 NM_026369 Actin related protein 2/3 complex, subunit 5 0.22 −0.35
21 Fndc3b NM_173182 Fibronectin type III domain containing 3B 0.22 −0.25
22 Slco5a1 NM_172841 Solute carrier organic anion transporter family, member 5A1 0.22 −0.24
23 Panx2 NM_001002005 Pannexin 2 0.22 −0.13
24 Slc30a4 NM_011774 solute carrier family 30 (zinc transporter), Member 4 0.22 −0.11
25 Agfg1 NM_010472 ArfGAP with FG repeats 1 0.22 −0.11
26 Mfap3l NM_001177881 Microfibrillar-associated protein 3-like 0.22 −0.10
27 Anxa7 NM_001110794 Annexin A7 0.22 −0.10
28 Celf6 NM_175235 CUGBP, Elav-like family member 6 0.22 −0.10
29 Ubr2 NM_001177374 Ubiquitin protein ligase E3 component n-recognin 2 0.22 −0.09
30 Cramp1l NM_020608 Crm, cramped-like (Drosophila) 0.22 −0.09
31 Nrg3 NM_001190187 Neuregulin 3 0.22 −0.08
32 Man2a1 NM_008549 Mannosidase 2, alpha 1 0.22 −0.08
33 Tbc1d14 NM_001113362 TBC1 domain family, member 14 0.21 −0.32
34 Tcf4 NM_001083967 mRNAion factor 4 0.21 −0.24
Targets of miR-190b predicted by TargetScanMouse are shown. Targets were sorted based on the aPCT (>0.2) and total context (TC;<-0.07) scores, which represent
the aggregated probability of conserved targeting and predictions based on four features of the putative microRNA-binding site, respectively. For each target, its
symbol, a representative mRNA, and full name of the gene from which the target is produced are shown.
and outgrowth. The effect of miR-219a-5p seems to be small
and mainly limited to slits-related guidance cues and (partially)
semaphorins cues, whereas the netrins and ephrins cues were
affected exclusively by the positively correlated miRNAs (miR-
28a-5p, miR-340-5p, and miR-491-5p). Thus, the combinatorial
effect of all miRNAs correlated with impulsivity on the KEGG
axonal guidance pathway is carried out mostly by the miR-
NAs that are positively correlated with impulsivity (Figure 5).
Considering that positive correlations mean that an increase in
impulsivity is associated with an increase in miRNA expression
in the amygdala, and since the main action of miRNAs is suppres-
sion of its targets, we concluded that the miRNAs correlating with
impulsivity most likely attenuate axon repulsion in the amygdala
(Figure 5).
Two other pathways were commonly regulated by both the
positively- and the negatively-correlated miRNAs. These were
Wnt signaling and endocytosis (Table 7). Similarly to the axonal
guidance, both of these pathways seem to be more affected
by the positively correlated miRNAs (miR-28a-5p, miR-340-
5p, and miR-491-5p) rather then the negatively correlated one
(miR-219a-5p), of which the effect on these pathways is barely
significant (Table 7).
In summary, our comprehensive bioinformatic analysis
seems to indicate that miRNAs in the amygdala may con-
tribute to the development of the impulsivity trait. On one
hand, miR-190b-5p seems to control synaptic activity, whereas
other miRNAs (primarily miR-340-5p) may control axonal
guidance.
www.frontiersin.org December 2014 | Volume 8 | Article 389 | 11
Pietrzykowski and Spijker Impulsivity and compulsivity regulated by amygdala miRNAs
FIGURE 4 | Impulsivity-related miR-190b and Nrg3 expression network
in amygdala. (A,B) Networks of reciprocal interactions of 34 targets (black)
of Nrg3 selected based on GeneMania stringent interaction criteria (for full
names see Table 5), weighted equally by network (a), or weighted for
biological process (B). A maximum of 10 additional genes is shown (gray).
Highlighted (encircled) are gene products and their interactions directly linked
to Nrg3. (C,D) Nrg3 network of closely interacting gene products, with direct
miR-190b-5p targets (black) and associated genes (dark gray) (see A,B) and
their contribution to gene ontology (GO) biological processes in the
Nrg3-network (color-coded: yellow, synaptic organization and genesis; green,
synaptic function; orange, mRNA processing). A legend describing interaction
categories is shown. Link thickness corresponds to strength (weight) of the
interaction, and size of shape (gray only) indicates the weight of the
interaction in the network.
DISCUSSION
Impulsive action, the tendency to act “on a spot” without a fore-
sight and the inability to inhibit such a prepotent response, is a
complex behavioral trait. This type of impulsivity can be advan-
tageous in situations requiring a rapid response, but often is
detrimental and associated with psychiatric disorders. Impulsivity
is moderately heritable (Kuntsi et al., 2006; Schachar et al., 2011;
Crosbie et al., 2013), which suggests partial genetic etiology
(Bevilacqua and Goldman, 2013). We have recently established
the presence of a genetic locus formotor impulsivity in the genetic
resource of BXD strains demonstrating an important role for
Nrg3 in the mPFC (Loos et al., 2014).
Here, we observed that in BXD mice the impulsivity trait
is significantly associated with traits relevant to psychiatric
disorders: attention, depression, metabolism and forms of anx-
iety. Indeed, impulsive behavior is augmented in several psy-
chiatric disorders, of which the most well-known is ADHD, in
which it is one of the DSM-V criteria (American Psychiatric
Association). The negative correlations of impulsivity with atten-
tion parameters, such as the % of correct responses as found here
(Figure 1), are well-known and have been previously observed in
different strains or pertubations (Loos et al., 2009; Counotte et al.,
2011; Agnoli and Carli, 2012). A concerted, balanced relationship
between attention and behavioral inhibition is central to the exec-
utive functionmodel and effective adaptation to an ever-changing
environment (Bari and Robbins, 2013).
In addition, impulsivity is often observed in bipolar patients,
and co-occurs with periods of mania (McElroy et al., 1996;
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Table 7 | Biological pathways regulated by microRNAs correlated
with impulsivity trait.
KEGG biological pathway P-value
miR-28a, miR-340, and miR-491
Axon guidance 2.18E-09
Wnt signaling pathway 1.46E-07
Endocytosis 2.38E-07
MAPK signaling pathway 1.28E-05
Focal adhesion 1.40E-05
miR-219a
Endocytosis 1.45E-02
Circadian rhythm 2.81E-02
Axon guidance 3.34E-02
Wnt signaling pathway 4.73E-02
Enriched pathways related to neuronal functions are shown. Contribution of
miR-28a-5p, miR-340-5p and miR-491-5p was assessed simultaneously due to
their synchronized positive correlation. We have analyzed miR-219a separately
because it was the only miRs correlated negatively with impulsivity. Analysis
was performed using DIANA mirPath algorithm and KEGG software with FDR
correction. P-value < 0.05 was considered significant.
Lombardo et al., 2012). Interestingly, a positive family history
of bipolar disorder could indicate an elevated risk to develop
bipolar disorder in children with ADHD (Sachs et al., 2000).
Many animal models of depression try to capture aspects of the
disease in the anxiety domain, with classical anxiety tests, such
as response to novelty in an open field or elevated plus maze,
and test that assess helplessness and a low effort to escape, such
as the tail suspension test and forced swim test (Palanza, 2001;
Krishnan and Nestler, 2011; Zhu et al., 2014). Immobility in a
tail suspension test (traits #11946, #11432), serving as proxy for
depression, was negatively correlated with impulsivity. Although
this is of interest from a clinical perspective, motor impulsiv-
ity could easily be confused with symptoms of hyperactivity in
preclinical models. However, neither in our dataset, nor in the
BXD dataset in GeneNetwork, locomotor activity in an open field
is correlated with our impulsivity trait. This apparent lack of a
correlation between impulsivity and activity in response to nov-
elty has been observed before (Loos et al., 2009). Therefore, the
correlation between impulsivity and immobility could indicate a
shared biological mechanism.
Whereas motor impulsivity deals with acting before think-
ing despite possible adverse consequences, compulsivity entails
actions that are persistently repeated despite adverse conse-
quences (Robbins et al., 2012). Both psychological constructs
have been hypothesized to result from failures of response inhi-
bition or “top-down” cognitive control with overlapping mech-
anisms and brain areas involved (Wolters et al., 2008; Robbins
et al., 2012; Callesen et al., 2013). Compulsivity is conceived as
maladaptive behavior contributing to drug-taking, or excessive
eating. In this respect, the positive correlation between impul-
sivity and several metabolism traits (Figure 1) in BXD mice may
not come as a surprise. Recent studies showed that impulsiv-
ity scores in humans are associated with additive consumption
of food and subsequently high BMI (Murphy et al., 2013). This
www.frontiersin.org December 2014 | Volume 8 | Article 389 | 13
Pietrzykowski and Spijker Impulsivity and compulsivity regulated by amygdala miRNAs
FIGURE 5 | Axonal guidance KEGG pathway and its regulation by
microRNAs correlated with impulsivity. Gene products targeted by
miR-28a-5p, miR-340-5p, and miR-491-5p are shown in red, a
miR-219a-5p target in green, and the miR-340-5p/miR-219a-5p targets in
yellow. Axonal guidance is broken down into groups controlled by
specific guidance cues (netrins, ephrins, slits, and semaphorins) for
clarity. The final, putative effects on axonal attraction, repulsion and
outgrowth are color-coded: inhibition is depicted by a small red box
next to the arrowhead, stimulation by a yellow box, while no effect by
a gray box.
association occurs early in life, as impulsivity is a risk factor for
child-obesity (van den Berg et al., 2011; Thamotharan et al., 2013)
and obese adolescent individuals have been reported as being
more impulsive (Delgado-Rico et al., 2013). This association per-
sists into adulthood (Sutin et al., 2013). Moreover, in psychiatric
patients with bipolar disorder the co-occurrence of impulsivity
and obesity worsens the prognosis (Galvez et al., 2014).
Since their discovery about 10 years ago, miRNA regulation of
gene expression became widely accepted as a fundamental biolog-
ical process (Farh et al., 2005; Guo et al., 2010). Typically, miRNAs
destabilize targeted mRNAs that subsequently undergo degrada-
tion. We showed here that expression of miR-190b-5p, but not
other miRNAs targeting Nrg3 mRNAs, is highly correlated with
impulsivity. This correlation is negative, which supports a sup-
pressive role of miR-190b-5p onNrg3 gene expression. Moreover,
expression of miR-190b-5p is negatively correlated with two body
mass traits and food intake that significantly correlate with impul-
sivity (Figure 3). Based on this, we could hypothesize that the
shared mechanism between impulsivity and compulsivity could
lie in regulation of a miR-190b-5p-directed network.
One of the challenges in understanding miRNAmechanisms is
themultiplicity of their actions, in which onemiRNA can regulate
several targets, and simultaneously a single target can be regu-
lated by several miRNAs. Here, we focused on a selection of the
network that is targeted by miR-190b-5p, and that is related to
biological relevance of Nrg3. Nrg3 is a part of a complex, inter-
twined biological network, in which this growth factor can bind
and activate Erbb4, a receptor tyrosine kinase (Zhang et al., 1997;
Rochat et al., 2008). Erbb4 can upon activation regulate a wide
range of biochemical pathways in a cell. Importantly, the expres-
sion of Nrg3 is mainly restricted to the nervous system (Zhang
et al., 1997; Evenden, 1999). Mutations in Nrg3 have recently
been reported to increase the risk for schizophrenia, and to alter
activation of the PFC in humans (Kao et al., 2010; Gupta et al.,
2011; Tost et al., 2014). In particular, Nrg3 and ErbB4 could play
an important neurodevelopmental role contributing to aberrant
cognitive function and social behaviors (Depue et al., 2014; Loos
et al., 2014) (Koob, 2009; Koob and Volkow, 2010; Paterson and
Law, 2014; Tost et al., 2014). However, Nrg3 has a role beyond
this developmental period (Lee et al., 1993; Wightman et al.,
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1993; Loos et al., 2014), probably maintaining synaptic structures
during adulthood. In this respect, the role of miRNAs is impor-
tant, because the network found for miR-190b-5p targets and
associated genes includes those that have a function in synapse
formation and stabilization. Recently, miR-190 has been shown to
be involved in regulation of synapses by drugs of abuse. Fentanyl
(but not morphine) decreases miR-190 levels and thereby regu-
lates NeuroD by binding to its 3′-UTR (Ambros and Lee, 2004;
Landgraf et al., 2007; Friedman et al., 2009; Zheng et al., 2010).
NeuroD is critical for dendritic spine stability without affecting
axon growth (Gaudillière et al., 2004; Siegel et al., 2011). One
of the direct targets of the miR-190b-5p network is neuroligin
(Nlgn1), which is a key synaptic factor that mediates the forma-
tion andmaintenance of synapses. It acts as a cell adhesion protein
expressed in the post-synaptic compartment, and interacts with
ß-neurexins located pre-synaptically. Together, neuroligin and ß-
neurexins hold both synaptic compartments close to each other,
helping to create a synaptic cleft. Importantly, alterations in
expression of neuroligin are linked to psychiatric diseases, specif-
ically autism spectrum disorders (Farh et al., 2005; Lewis et al.,
2005; Südhof, 2008).
Besides miR-190b-5p, the expression of miR-340-5p, miR-28a
and miR-491 in the amygdala was negatively correlated with
impulsivity. Whereas miR-340-5p was detected as downregu-
lated with age in serum (Im and Kenny, 2012; Xu et al., 2012;
Nestler, 2014; Zhang et al., 2014), miR-340-5p was upregulated
in the hippocampus of FMRP mice (Hébert and De Strooper,
2009; Liu et al., 2014), a neurodevelopmental model characterized
by more immature dendritic spines (Bassell and Warren, 2008;
Pietrzykowski, 2010). Likewise, in melanocytes, miR-340 is able
to increase dendritic formation (Sánchez-Mora et al., 2013; Jian
et al., 2014). In this respect, the negative correlation of miR-340-
5p with impulsivity could relate to a decrease in synaptic plasticity
in the amygdala of impulsive mice.
As yet, miR-28a-5p and miR-491-5p have been mainly stud-
ied in cancer, and more specifically in the formation of gliomas
(Malzkorn et al., 2010; Németh et al., 2013; Li et al., 2014). Both
derivatives of the mir-491 precursor, miR-491-5p and -3p control
key hallmarks of glioma carcinogenesis, repressing proliferation
(Li et al., 2014; Loos et al., 2014). In addition, in the PFC of
depressed patients, as well as in serum of schizophrenic patients,
a decrease in miR-491-3p is observed (Cole and Robbins, 1989;
Shi et al., 2012; Serafini et al., 2014). Moreover, the expression
of miR-219-5p, which was positively correlated with impulsivity,
is downregulated in gliomas. This is in concordance with its role
in inhibiting proliferation of medulloblastoma cells and migra-
tion of glioma cells, as well as promoting neural differentiation
(Hudish et al., 2013; Rao et al., 2013; Shi et al., 2014). The role
of miR-219 in the brain is limited to being downregulated upon
disruption of NMDAR signaling in the PFC, and downregulation
of miR-219 inhibits the NMDAR antagonist dizocilpine-induced
effect on locomotion and stereotypy (Kocerha et al., 2009). Taken
together, although a role for these miRNAs in alterating synap-
tic plasticity, in part, through the changes in development of
spines or dendrites seems likely, this has not been established yet.
Based on our results, we propose here that miR219-5p along with
miR-340-5p, miR-28a-5p and possibly miR-491-5p could have
a key role in the development of psychiatric diseases, possibly
by affecting the balance between neuronal outgrowth and dif-
ferentiation in the context of synapse plasticity, maturation and
maintenance.
CONCLUSIONS
Our goal here was to use multiple bioinformatic resources to
select miRNAs relevant to impulsivity. Our data suggest that miR-
190b-5p is a strong candidate of a biological network regulation
centered around Nrg3 in relation to impulsive and compulsive
traits. This network could affect synaptic processes in amygdala.
On a critical note, these findings stem from big datasets, which
also could have larger (technical) variation, and therefore need
validation at multiple levels. On the other hand, the strict criteria
that we have applied, in combination with the fact that we tested
a selective hypothesis should be a more powerful approach reduc-
ing false-positives, as suggested before (Chesler et al., 2005), and
therefore lead to a specific set of experiments that can be tested in
the lab. These could entail performing quantitative gene expres-
sion (e.g., real-time PCR) for miRs, Nrg3 and target genes, as
well as protein levels for Nrg3 and target genes (e.g., quantitative
proteomics), in different BXD strains, or after intervention (e.g.,
RNA interference) of either levels of Nrg3 (Nrg3 KO, Nrg3 over-
expression) or specific miRs. Although we focused here on the
amygdala, because of its role in emotional aspects of impulsivity,
it is evident that impulsivity stems from the complex interac-
tions of several brain regions, including the striatum and cortical
regions (Crews and Boettiger, 2009; Basar et al., 2010; Kerr et al.,
2014). Therefore, it will be of great interest to show directly a role
of these miRNAs in impulsivity and compulsivity in these brain
regions by wet lab experiments, as mentioned above.
Psychiatric disorders are complex amalgamations of behav-
ioral traits rooted in molecular mechanisms. With the emerging
role of miRNAs as major regulators of gene and protein expres-
sion, and cellular function, they are also attractive targets for
therapeutic approaches (Dinan, 2010; Chan and Kocerha, 2012).,
We propose here that a set of miRNAs contributes to the regu-
lation of synaptic plasticity in the amygdala, which could bring
us a little bit closer to understanding mechanisms in psychiatric
disorders and creating new therapeutic options.
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